GLOBAL PIVOTAL PHASE 2 TRIAL OF THE CD19-TARGETED THERAPY CTL019 IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA - AN INTERIM ANALYSIS Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Schuster, SJ
  • Bishop, MR
  • Tam, C
  • Waller, EK
  • Borchmann, P
  • McGuirk, J
  • Jaeger, U
  • Jaglowski, S
  • Andreadis, C
  • Westin, J
  • Fleury, I
  • Bachanova, V
  • Foley, Ronan
  • Ho, PJ
  • Mielke, S
  • Magenau, JM
  • Holte, H
  • Anak, O
  • Pacaud, L
  • Awasthi, R
  • Tai, F
  • Salles, G
  • Maziarz, RT

publication date

  • June 26, 2017